Vitamin D2 and D3 Separation by New Highly Hydrophobic UHPLC/HPLC Phase
The Application Notebook
Separations of structurally similar compounds such as vitamin D2 and vitamin D3 are very challenging.
Vitamin D2 (ergocalciferol) and D3 (cholecalciferol) can be found in different foods including fatty fishes, meat, egg, and some mushrooms. Both compounds are (indirectly) involved in a number of biological functions in the body, including bone metabolism and enhancement of intestinal absorption of calcium, iron, magnesium, phosphate, and zinc. A regular intake of vitamin D therefore is essential.
Figure 1: Structures of vitamin D2 and vitamin D3.
Standard C18 columns are not able to fully separate the two vitamins. A very hydrophobic phase with a higher carbon coverage and therefore a greater density of C18 chains is required. The highly hydrophobic phase YMC-Triart C18 ExRS (carbon load 25%!) is able to separate these two.
Figure 2: Easy method transfer HPLC <-> UHPLC as a result of full scalability.
The isocratic high performance liquid chromatography (HPLC) method for vitamin D2 and D3 separation, using a 5 μm YMC-Triart C18 ExRS column, can easily be transferred to a ultrahigh-performance liquid chromatography (UHPLC) method using a 1.9 μm column, thereby reducing the analysis time by 50%. Furthermore, the resolution can be increased, resulting in a full baseline separation.
YMC-Triart C18 ExRS (5 µm, 8 nm), 150 × 3.0 mm
YMC-Triart C18 ExRS (1.9 µm, 8 nm),
75 × 2.1 mm
YMC Europe GmbH
Phone: +49 2064 4270
E-mail: info@ymc.de
Website: www.ymc.de
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
